Mechanisms of Reactivation of Epstein-Barr Virus from Latency to Lytic Replicatio

EB病毒从潜伏期到裂解复制的再激活机制

• 批准号: 7465914
• 负责人: Janet Elaine Mertz
• 金额: $ 20.01万
• 依托单位: UNIVERSITY OF WISCONSIN-MADISON
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-05-01 至 2013-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7465914
• 关键词: Area; B-Lymphocytes; BZLF1 protein, Herpesvirus 4, Human; Burkitt Lymphoma; Cell Death; Cell Differentiation process; Cell Line; Cells; Disease; EBV reactivation from latency; EBV-associated disease; Elements; Epithelial; Epithelial Cells; Epstein-Barr Virus Infections; Epstein-Barr Virus latency; Equilibrium; Genes; Herpesviridae; Hodgkin Disease; Human; Human Herpesvirus 4; Immediate-Early Genes; Immunization; Immunocompromised Host; Individual; Infection; Knowledge; Lead; Lytic; Malignant Neoplasms; Mediating; Molecular Biology; Nasopharynx Carcinoma; Non-Hodgkin' s Lymphoma; Papilloma; Pathogenesis; Play; Proteins; Regulation; Role; Signal Pathway; Signal Transduction; Simplexvirus; Stomach Carcinoma; Vaccines; Viral; Viral Genes; Virus; cell type; infected B cell; latent infection; lytic gene expression; lytic replication; mutant; promoter; research study; therapy development; tumor

Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus virus that can infect both B lymphocytes and epithelial cells. Depending upon the cell type and its state of differentiation, infection by EBV leads to either lytic replication with cell death or a latent infection. Latent EBV infections are associated with several B-cell and epithelial-cell malignancies including Burkitt's lymphoma, Hodgkin's disease, non-Hodgkin's lymphomas in immunocompromised individuals, nasopharyngeal carcinoma, and some gastric carcinomas. Thus, understanding regulation of EBV latency versus lytic replication is crucial for developing therapies to treat these diseases. The BZLF1 and BRLF1 genes of EBV encode multifunctional proteins essential for lytic replication. While the BZLF1 and BRLF1 promoters are inactive in latently infected cells, cell differentiation and activators of certain cell signaling pathways can induce BZLF1 and BRLF1 expression, promoting EBV reactivation into lytic replication. In this Project, we will (i) identify cellular factors that play key roles in regulating expression of these two immediate-early genes in both B cells and epithelial cells, and (ii) examine how these factors contribute to controlling the balance between latent and lytic EBV infection in a variety of cell types and during cellular differentiation. In conjunction with Project 5, these results may lead to new therapies for treating EBV-associated cancers.

EB病毒（EBV）是一种普遍存在的人疱疹病毒，其可以感染B淋巴细胞和 上皮细胞根据细胞类型及其分化状态，EBV感染导致 伴随细胞死亡或潜伏感染的裂解性复制。潜伏性EB病毒感染与几种B细胞 和上皮细胞恶性肿瘤，包括伯基特淋巴瘤、霍奇金病、非霍奇金淋巴瘤 在免疫功能低下的个体、鼻咽癌和一些胃癌中。因此，本发明的目的是， 了解EB病毒潜伏期与裂解性复制的调节对于开发治疗方法至关重要， 这些疾病。EB病毒BZLF1和BRLF1基因编码多功能裂解必需蛋白 复制的虽然BZLF 1和BRLF 1启动子在潜伏感染的细胞中是无活性的，但细胞分化 某些细胞信号通路的激活剂可以诱导BZLF1和BRLF1的表达，促进EBV 再活化为裂解性复制。在本项目中，我们将（i）确定在以下方面发挥关键作用的细胞因子： 调节这两种即刻早期基因在B细胞和上皮细胞中的表达，和（ii） 检查这些因素如何有助于控制潜伏性和溶解性EB病毒感染之间的平衡 细胞类型的多样性和细胞分化过程中。结合项目5，这些结果可能会导致 用于治疗EBV相关癌症的新疗法。